Your browser doesn't support javascript.
loading
Pharmacokinetics and safety of glecaprevir and pibrentasvir in HCV-negative subjects with hepatic impairment.
Kosloski, Matthew P; Wang, Haoyu; Pugatch, David; Mensa, Federico J; Gane, Edward; Lawitz, Eric; Marbury, Thomas C; Preston, Richard A; Kort, Jens; Liu, Wei.
Afiliación
  • Kosloski MP; Clinical Pharmacology and Pharmacometrics, AbbVie Inc., North Chicago, IL, USA.
  • Wang H; Data and Statistical Sciences, AbbVie Inc., North Chicago, IL, USA.
  • Pugatch D; Infectious Diseases, AbbVie Inc., North Chicago, IL, USA.
  • Mensa FJ; Infectious Diseases, AbbVie Inc., North Chicago, IL, USA.
  • Gane E; University of Auckland, Auckland, New Zealand.
  • Lawitz E; Texas Liver Institute, University of Texas Health, San Antonio, TX, USA.
  • Marbury TC; Orlando Clinical Research Center, Orlando, FL, USA.
  • Preston RA; Division of Clinical Pharmacology, Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL, USA.
  • Kort J; Department of Cellular Biology and Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, USA.
  • Liu W; Medical Affairs, AbbVie Inc., North Chicago, IL, USA.
Eur J Clin Pharmacol ; 75(2): 217-226, 2019 Feb.
Article en En | MEDLINE | ID: mdl-30341499

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Quinoxalinas / Sulfonamidas / Bencimidazoles / Hepatopatías Límite: Adolescent / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Clin Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Quinoxalinas / Sulfonamidas / Bencimidazoles / Hepatopatías Límite: Adolescent / Female / Humans / Male / Middle aged Idioma: En Revista: Eur J Clin Pharmacol Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Alemania